167 related articles for article (PubMed ID: 35737702)
1. CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells.
Mao DD; Cleary RT; Gujar A; Mahlokozera T; Kim AH
PLoS One; 2022; 17(6):e0270251. PubMed ID: 35737702
[TBL] [Abstract][Full Text] [Related]
2. A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells.
Mao DD; Gujar AD; Mahlokozera T; Chen I; Pan Y; Luo J; Brost T; Thompson EA; Turski A; Leuthardt EC; Dunn GP; Chicoine MR; Rich KM; Dowling JL; Zipfel GJ; Dacey RG; Achilefu S; Tran DD; Yano H; Kim AH
Cell Rep; 2015 Jun; 11(11):1809-21. PubMed ID: 26074073
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.
Kanai R; Rabkin SD; Yip S; Sgubin D; Zaupa CM; Hirose Y; Louis DN; Wakimoto H; Martuza RL
J Natl Cancer Inst; 2012 Jan; 104(1):42-55. PubMed ID: 22173583
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of checkpoint kinase 1 is associated with the increased radiosensitivity of glioblastoma stem-like cells.
Wu J; Lai G; Wan F; Xiao Z; Zeng L; Wang X; Ye F; Lei T
Tohoku J Exp Med; 2012 Apr; 226(4):267-74. PubMed ID: 22481303
[TBL] [Abstract][Full Text] [Related]
5. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
[TBL] [Abstract][Full Text] [Related]
6. CDC20 maintains tumor initiating cells.
Xie Q; Wu Q; Mack SC; Yang K; Kim L; Hubert CG; Flavahan WA; Chu C; Bao S; Rich JN
Oncotarget; 2015 May; 6(15):13241-54. PubMed ID: 25938542
[TBL] [Abstract][Full Text] [Related]
7. L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.
Cheng L; Wu Q; Huang Z; Guryanova OA; Huang Q; Shou W; Rich JN; Bao S
EMBO J; 2011 Mar; 30(5):800-13. PubMed ID: 21297581
[TBL] [Abstract][Full Text] [Related]
8. CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression.
Yang C; Ge Y; Zang Y; Xu M; Jin L; Wang Y; Xu X; Xue B; Wang Z; Wang L
Apoptosis; 2023 Dec; 28(11-12):1584-1595. PubMed ID: 37535214
[TBL] [Abstract][Full Text] [Related]
9. Recognizing and correcting failures in glioblastoma treatment.
Shah AH; Graham R; Bregy A; Thambuswamy M; Komotar RJ
Cancer Invest; 2014 Jul; 32(6):299-302. PubMed ID: 24766304
[TBL] [Abstract][Full Text] [Related]
10. RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation.
Yuan M; Eberhart CG; Kai M
Oncotarget; 2014 May; 5(9):2820-6. PubMed ID: 24811242
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
[TBL] [Abstract][Full Text] [Related]
12. The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.
Kahn J; Hayman TJ; Jamal M; Rath BH; Kramp T; Camphausen K; Tofilon PJ
Neuro Oncol; 2014 Jan; 16(1):29-37. PubMed ID: 24311635
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CDC20 Increases Radiosensitivity through Mcl-1/p-Chk1-Mediated DNA Damage and Apoptosis in Tumor Cells.
Gao Y; Wen P; Chen B; Hu G; Wu L; Xu A; Zhao G
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932732
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer.
Rodriguez SMB; Staicu GA; Sevastre AS; Baloi C; Ciubotaru V; Dricu A; Tataranu LG
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562993
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2.
Bouchart C; Trépant AL; Hein M; Van Gestel D; Demetter P
Cancer Med; 2020 Feb; 9(3):1069-1078. PubMed ID: 31568682
[TBL] [Abstract][Full Text] [Related]
16. Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition.
Wang J; Zhou F; Li Y; Li Q; Wu Z; Yu L; Yuan F; Liu J; Tian Y; Cao Y; Zhao Y; Zheng Y
Cell Cycle; 2017; 16(24):2355-2365. PubMed ID: 29108461
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells.
Zhao K; Schäfer A; Zhang Z; Elsässer K; Culmsee C; Zhong L; Pagenstecher A; Nimsky C; Bartsch JW
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008590
[TBL] [Abstract][Full Text] [Related]
18. SPT6-driven error-free DNA repair safeguards genomic stability of glioblastoma cancer stem-like cells.
Obara EAA; Aguilar-Morante D; Rasmussen RD; Frias A; Vitting-Serup K; Lim YC; Elbæk KJ; Pedersen H; Vardouli L; Jensen KE; Skjoth-Rasmussen J; Brennum J; Tuckova L; Strauss R; Dinant C; Bartek J; Hamerlik P
Nat Commun; 2020 Sep; 11(1):4709. PubMed ID: 32948765
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.
Xi Z; Wang P; Xue Y; Shang C; Liu X; Ma J; Li Z; Li Z; Bao M; Liu Y
Oncotarget; 2017 Apr; 8(15):24949-24963. PubMed ID: 28212562
[TBL] [Abstract][Full Text] [Related]
20. Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance.
Atkins RJ; Stylli SS; Kurganovs N; Mangiola S; Nowell CJ; Ware TM; Corcoran NM; Brown DV; Kaye AH; Morokoff A; Luwor RB; Hovens CM; Mantamadiotis T
Exp Cell Res; 2019 Jan; 374(2):353-364. PubMed ID: 30562483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
